Cannabinoid treatment for autism: a proof-of-concept randomized trial
Cannabinoid treatment for autism: a proof-of-concept randomized trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cannabinoid treatment for autism: a proof-of-concept randomized trial have?
Cannabinoid treatment for autism: a proof-of-concept randomized trial has 223 citations in the OpenAlex counts ScholarIQ stores.
When was Cannabinoid treatment for autism: a proof-of-concept randomized trial published?
Cannabinoid treatment for autism: a proof-of-concept randomized trial has 2021 year in the ScholarIQ index.
What is the open-access status of Cannabinoid treatment for autism: a proof-of-concept randomized trial?
Cannabinoid treatment for autism: a proof-of-concept randomized trial has gold oa status in the ScholarIQ index.
What is the DOI of Cannabinoid treatment for autism: a proof-of-concept randomized trial?
The DOI for Cannabinoid treatment for autism: a proof-of-concept randomized trial is on the source record.
What is the PMID of Cannabinoid treatment for autism: a proof-of-concept randomized trial?
The PMID for Cannabinoid treatment for autism: a proof-of-concept randomized trial is on the source record.
What is the OpenAlex record for Cannabinoid treatment for autism: a proof-of-concept randomized trial?
The OpenAlex for Cannabinoid treatment for autism: a proof-of-concept randomized trial is on the source record.